Posted on 12/21/20
4 Reasons You Should Buy Pfizer Stock Right Now
The ongoing rollout of the first authorized coronavirus vaccine has heaps of everyday investors wondering if Pfizer (NYSE:PFE), the company credited with making it happen so . . .
Posted on 12/21/20
CVS: Crushing The Market One Stock At A Time
Summary CVS exhibits a consumer defensive business with strong competitive advantages.CVS is in great financial shape, growth prospects remain encouraging, and the stock is significantly undervalued.CVS . . .
Posted on 12/21/20
Where Will Biogen Be in 5 Years?
Biogen (NASDAQ:BIIB) is a large-cap biotech that has witnessed significant volatility this year, with over 40% price swings in both directions. As it turns out, market . . .
Posted on 12/21/20
Does Pfizer's Vaccine Authorization Improve Moderna's Chances?
Pfizer(NYSE:PFE) received U.S. Emergency Use Authorization (EUA) for its COVID-19 vaccine on Dec. 11, 2020. This has raised hopes that Moderna(NASDAQ:MRNA) could soon win EUA for . . .
Posted on 12/21/20
Will Moderna Stock Hit $200 in 2021?
Moderna (NASDAQ:MRNA) has been one of the leaders in the race to develop a coronavirus vaccine, and as a result, its shares have soared by more . . .
Posted on 12/21/20
Moderna to Provide 80 Million Additional Doses of Coronavirus Vaccine to European Authorities
Once again, a recipient of Moderna's (NASDAQ:MRNA) mRNA-1273 coronavirus vaccine candidate is exercising its option for more doses. On Friday, the company announced that the European . . .
Posted on 12/21/20
Moderna Gains FDA Authorization for Its Coronavirus Vaccine
The Food and Drug Administration authorized a second coronavirus vaccine on Friday. The emergency use authorization (EUA) for Moderna's (NASDAQ:MRNA) mRNA-1273 comes just a day after . . .
Posted on 12/20/20
Maryland Confirms More Than 2,000 New Cases For 18th Straight Day
Maryland on Friday confirmed more than 2,000 new coronavirus cases for the 18th consecutive day.Before December, the state had only seen 10 other days of the . . .
Posted on 12/18/20
Sensible Medical Brings the Portable JADE Commercial Grade Air Purification System to Hospitals, Clinics and Offices Across the U.S.
Sensible Medical, a Hanover, MA distributor of medical grade air purification systems for hospitals, clinics and offices announces that it is the authorized USA distributor for . . .
Posted on 12/18/20
Scopus BioPharma Closes of IPO
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of its initial public offering. The underwriters for the initial public offering exercised their over-allotment option in . . .
Posted on 12/18/20
Greenwich LifeSciences Prices $26.4 Million Upsized Public Offering of Common Stock
STAFFORD, Texas--(BUSINESS WIRE)--Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients . . .
Posted on 12/18/20
TPG and TA Associates Close on $1.6 Billion Planview Acquisition from Thoma Bravo
AUSTIN, Texas & SAN FRANCISCO & FORT WORTH, Texas & BOSTON--(BUSINESS WIRE)--TPG Capital, the private equity platform of global alternative asset firm TPG, and TA Associates, . . .
Posted on 12/18/20
MacroGenics Enters Research Collaborate with Janssen
ROCKVILLE, MD, Dec. 18, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment . . .
Posted on 12/18/20
Why Didn't Pfizer Stock Jump More After Winning Authorization for Its COVID Vaccine?
Pfizer(NYSE:PFE) received great news last Thursday that an advisory committee to the U.S. Food and Drug Administration (FDA) overwhelmingly recommended Emergency Use Authorization (EUA) for its . . .
Posted on 12/18/20
Will Moderna Stock Soar If Its COVID Vaccine Is Authorized?
Pfizer's (NYSE:PFE) share price actually fell a little after an advisory committee to the U.S. Food and Drug Administration (FDA) recommended Emergency Use Authorization (EUA) for . . .
Posted on 12/18/20
Will Moderna Stock Soar If Its COVID Vaccine Is Authorized?
Pfizer's (NYSE:PFE) share price actually fell a little after an advisory committee to the U.S. Food and Drug Administration (FDA) recommended Emergency Use Authorization (EUA) for . . .
Posted on 12/18/20
FDA Advisers Vote Unanimously Recommending Authorization of Moderna's Coronavirus Vaccine
After a full day of discussions, the Food and Drug Administration (FDA) advisory committee voted unanimously to recommend authorization of mRNA-1273, Moderna's (NASDAQ:MRNA) coronavirus vaccine. There . . .
Posted on 12/18/20
Coronavirus Hospitalizations in Maryland Decline But Remain at 10th Highest Point of Pandemic
Coronavirus-related hospitalizations in Maryland decreased for the second day in a row on Thursday but the metric remains above 1,700, with the 10th highest daily total . . .
Posted on 12/17/20
Holy Cross Health Adds Two Physicians, Elena Pimanova and Ronald Pham
Holy Cross Medical Group, a multi-specialty physician employed group of more than 160 physicians providing
Posted on 12/17/20
Healthworx Announces First Entrepreneur-in-Residence Jason Hardebeck
Today, Healthworx announces the hire of Jason Hardebeck as their first Entrepreneur-in-Residence
Posted on 12/17/20
CSCI Providing Premier Healthcare For Team And Families
Partners with Privia to Deliver COVID-19 Care CoordinationCSCI has always provided great care and resources for its team members both medically and from a training perspective. . . .
Posted on 12/17/20
Gamida Cell Prices of $65 Million Public Offering of Ordinary Shares
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the pricing of . . .
Posted on 12/17/20
Cadent Therapeutics to be Acquired by Novartis
Cadent Therapeutics, a privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders,
Posted on 12/17/20
Gamida Cell Launch of Public Offering of Ordinary Shares
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the launch of . . .
Posted on 12/17/20
Virios Therapeutics Prices of IPO
ATLANTA--(BUSINESS WIRE)--Virios Therapeutics, Inc., a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, today announced . . .

